Headline
The latest stories from AHA Today.
The Centers for Medicare & Medicaid Services announced that the agency will pay for Medicare beneficiaries’ booster doses, without cost sharing.
AHA, joined by the Association of American Medical Colleges, filed an amicus brief in response to the Federal Trade Commission’s challenge to a hospital merger in New Jersey in the U.S. Court of Appeals for the 3rd Circuit.
AHA urged the Office of the United States Trade Representative to extend the current Section 301 tariff exemptions for certain medical devices to ensure hospitals and health systems have the supplies they need to continue to safely and effectively care for all patients. Without an extension, the…
The Centers for Disease Control and Prevention early Friday morning opted for a broad endorsement of Pfizer COVID-19 vaccine booster shots, issuing interim guidance that recommends boosters for many vaccinated individuals, including those in high-risk occupational and institutional settings.
The AHA urged the Health Resources and Services Administration to quickly distribute the $17 billion in Phase 4 provider relief funds and $8.5 billion in American Rescue Plan Act funds for rural providers, as well as reverse a new requirement that capital projects be fully completed before the…
The Cybersecurity and Infrastructure Security Agency, FBI and National Security Agency yesterday issued an advisory to help organizations secure their systems against Conti ransomware attacks, which have included health care targets in the U.S. and other countries.
HCA Healthcare and its Tulane Health System in New Orleans have donated $225,000 to community organizations to aid in Hurricane Ida recovery and relief efforts.
U.S. overdose deaths involving psychostimulants other than cocaine, largely methamphetamine, increased 180% among adults under age 65 between 2015 and 2019, to 15,489, according to a study by the National Institute on Drug Abuse published this week in JAMA Psychiatry. The number of people reporting…
John Riggi, AHA’s senior advisory for cyber security and risk, speaks with Edward You, supervisory special agent in the FBI’s Weapons of Mass Destruction Directorate, about the biggest national threats to the bioeconomy, medical research and innovation. Listen here.
Cordis Corporation recently recalled 25,000 catheters used to visualize and measure parts of the vascular system, due to the potential for their marker bands to move or dislodge during procedures. The Food and Drug Administration has identified this as a Class I recall due to the potential for…